Intravitreal Bevacizumab for Treatment of Bilateral Candida Chorioretinitis Complicated with Choroidal Neovascularization
| Autor: | Kirsten E. Zonnevylle, Dinu Stanescu-Segall |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
genetic structures Bevacizumab 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Amphotericin B Ophthalmology Immunology and Allergy Medicine Intravitreal bevacizumab 030203 arthritis & rheumatology medicine.diagnostic_test business.industry Chorioretinitis Fluorescein angiography medicine.disease eye diseases Vascular endothelial growth factor Regimen Choroidal neovascularization chemistry 030221 ophthalmology & optometry sense organs medicine.symptom business medicine.drug |
| Zdroj: | Ocular Immunology and Inflammation. 28:39-42 |
| ISSN: | 1744-5078 0927-3948 |
| DOI: | 10.1080/09273948.2019.1623268 |
| Popis: | Purpose: The purpose of this report is to describe a case of bilateral Candida chorioretinitis complicated with choroidal neovascularization (CNV) and effectively treated with combined intravitreal bevacizumab and amphotericin B.Results: An 83-year-old patient was diagnosed with Candida chorioretinitis in both eyes. Optical coherence tomography and fluorescein angiography revealed CNV. Treatment using combined intravitreal bevacizumab and amphotericin B was initiated followed by a 4-weekly regimen of bevacizumab, eventually resulting in the regression of the subretinal fluid and intraretinal edema.Conclusion: Our study supports the combined use of intravitreal bevacizumab and amphotericin B in the management of CNV in Candida chorioretinitis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|